Fisher Asset Management LLC Sells 1,082 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Fisher Asset Management LLC decreased its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 24.2% during the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 3,391 shares of the company’s stock after selling 1,082 shares during the period. Fisher Asset Management LLC’s holdings in GE HealthCare Technologies were worth $318,000 at the end of the most recent quarter.

Other institutional investors have also bought and sold shares of the company. Van ECK Associates Corp acquired a new position in shares of GE HealthCare Technologies in the 3rd quarter valued at about $208,513,000. Massachusetts Financial Services Co. MA acquired a new position in GE HealthCare Technologies in the third quarter valued at approximately $93,713,000. Marshall Wace LLP bought a new position in shares of GE HealthCare Technologies during the 2nd quarter worth approximately $63,639,000. International Assets Investment Management LLC grew its position in shares of GE HealthCare Technologies by 10,227.3% during the 3rd quarter. International Assets Investment Management LLC now owns 621,913 shares of the company’s stock worth $58,367,000 after buying an additional 615,891 shares during the period. Finally, Charles Schwab Investment Management Inc. increased its stake in shares of GE HealthCare Technologies by 12.0% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 2,710,938 shares of the company’s stock valued at $254,422,000 after acquiring an additional 290,019 shares in the last quarter. Institutional investors own 82.06% of the company’s stock.

Insider Transactions at GE HealthCare Technologies

In other news, CEO Roland Rott sold 3,577 shares of the firm’s stock in a transaction that occurred on Wednesday, November 6th. The shares were sold at an average price of $86.48, for a total transaction of $309,338.96. Following the completion of the sale, the chief executive officer now owns 24,298 shares in the company, valued at $2,101,291.04. This trade represents a 12.83 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Company insiders own 0.27% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have commented on the stock. UBS Group cut shares of GE HealthCare Technologies from a “neutral” rating to a “sell” rating and reduced their price target for the stock from $84.00 to $74.00 in a report on Thursday, September 26th. BTIG Research upgraded GE HealthCare Technologies from a “neutral” rating to a “buy” rating and set a $100.00 target price for the company in a research note on Wednesday, September 18th. Evercore ISI upped their price target on GE HealthCare Technologies from $98.00 to $102.00 and gave the stock an “outperform” rating in a research note on Tuesday, October 1st. Stifel Nicolaus raised their price objective on GE HealthCare Technologies from $100.00 to $102.00 and gave the company a “buy” rating in a research note on Monday, September 30th. Finally, Wells Fargo & Company upped their target price on GE HealthCare Technologies from $95.00 to $96.00 and gave the stock an “overweight” rating in a research report on Thursday, October 31st. One investment analyst has rated the stock with a sell rating, four have issued a hold rating, eight have assigned a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, GE HealthCare Technologies currently has an average rating of “Moderate Buy” and a consensus target price of $95.46.

GE HealthCare Technologies Stock Up 0.3 %

GEHC opened at $83.22 on Monday. GE HealthCare Technologies Inc. has a fifty-two week low of $66.39 and a fifty-two week high of $94.55. The firm has a market capitalization of $38.02 billion, a P/E ratio of 22.86, a PEG ratio of 2.98 and a beta of 1.24. The company’s 50-day moving average is $87.78 and its 200 day moving average is $83.64. The company has a debt-to-equity ratio of 1.12, a current ratio of 1.23 and a quick ratio of 0.98.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its earnings results on Wednesday, October 30th. The company reported $1.14 EPS for the quarter, topping the consensus estimate of $1.06 by $0.08. The firm had revenue of $4.86 billion for the quarter, compared to analysts’ expectations of $4.87 billion. GE HealthCare Technologies had a net margin of 8.56% and a return on equity of 25.19%. The company’s quarterly revenue was up .9% compared to the same quarter last year. During the same quarter last year, the firm earned $0.99 EPS. Research analysts expect that GE HealthCare Technologies Inc. will post 4.3 earnings per share for the current fiscal year.

GE HealthCare Technologies Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 14th will be given a dividend of $0.035 per share. The ex-dividend date of this dividend is Tuesday, January 14th. This is a positive change from GE HealthCare Technologies’s previous quarterly dividend of $0.03. This represents a $0.14 annualized dividend and a dividend yield of 0.17%. GE HealthCare Technologies’s dividend payout ratio (DPR) is currently 3.30%.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.